Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.

ClinicalTrials.gov 5 recruiting now small index

Tuberous Sclerosis clinical trials

5 of 7 indexed Tuberous Sclerosis trials are currently recruiting.

Corpus placement: #2,497 of 28,707 conditions by registered trial count.

Jump to open trials → Trial finder

7 US clinical trials · 5 currently recruiting · #2,497 of 28,707 conditions by registered trial count

Tuberous Sclerosis: 7 US clinical trials tracked, 5 recruiting.

Tuberous Sclerosis is the subject of 7 registered US clinical trials on ClinicalTrials.gov, 5 of them currently open to new participants. The most active sponsor is National Heart, Lung, and Blood Institute (NHLBI), running 4 of these trials.

Enrollment posture brief

Registry condition tuberous-sclerosis

OPEN 5 | RECR 71% | LATE 0 | EARLY 0 | RANK #2497 | SPON 4

Volume-matched condition peers

Nearest open-share peer: Advanced Endometrial Carcinoma (71% recruiting · 7 trials)

ACL Tear71.4%Tuberous Sclerosis (this)71%ACL57.1%Acute Myelogenous Leukemia42.9%Acne Scars28.6%
Open-enrollment share among volume-matched conditions near Tuberous Sclerosis

Tuberous Sclerosis lists 5 open slots (71% of 7 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →

Key findings

What ClinicalTrials.gov does not surface for Tuberous Sclerosis on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.

  1. Tuberous Sclerosis is recruiting above its size-band peers.

    5 of 7 indexed trials (71.4%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.

  2. One sponsor concentrates Tuberous Sclerosis research.

    National Heart, Lung, and Blood Institute (NHLBI) accounts for 4 of 7 trials (57.1%). 4 distinct sponsors appear on at least one study for this condition label.

  3. Typical Tuberous Sclerosis enrolment sits around 400 participants.

    Median target enrolment is 400 among the 7 trials that report a genuine target (sentinel values excluded). 2 of those (28.6%) plan for fewer than 100 participants.

  4. Tuberous Sclerosis research leans observational.

    1 interventional and 6 observational studies make up this index (14.3% interventional). Study type is sponsor-reported on ClinicalTrials.gov.

Phase Distribution

Phase data not available

Top Sponsors

National Heart, Lung, and Blood Institute (NHLBI) 4 trials
National Tuberous Sclerosis Association 1 trials
Rush University Medical Center 1 trials
Boston Children's Hospital 1 trials

Named interventions

Most-linked intervention names on Tuberous Sclerosis records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.

Toshibia Aquilion One CT Device
1 trials
Tissue donation after routine clinical procedure Other
1 trials
Genetic Testing Genetic
1 trials
Buccal (cheek) swab Procedure
1 trials
Positive Parenting Strategies-Treatment as Usual Other
1 trials
Functional Behavioral Training (FBT) Behavioral
1 trials
Phlebotomy Procedure
1 trials

US sites by state

Facility locations filed on Tuberous Sclerosis trials. A trial with sites in several states counts in each.

Maryland 5 trials
Texas 2 trials
Ohio 2 trials
Massachusetts 2 trials
Illinois 2 trials
California 2 trials
Alabama 2 trials
Tennessee 1 trials

Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this Tuberous Sclerosis page

7 registered trials, 5 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Tuberous Sclerosis condition card totals 7 registered trials; most-linked intervention Toshibia Aquilion One CT; top US site state Maryland. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.